Capricor Therapeutics, Inc. (CAPR)
34.70
+0.11
(+0.32%)
USD |
NASDAQ |
Apr 17, 16:00
35.04
+0.34
(+0.98%)
After-Hours: 05:21
Capricor Therapeutics SG&A Expense (Quarterly) : 6.025M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 7.215M |
| Repligen Corp. | 74.36M |
| Vaxart, Inc. | 3.666M |
| Penumbra, Inc. | 181.10M |
| Allogene Therapeutics, Inc. | 13.77M |